Avivagen (CVE:VIV) Trading Down 7.4%

Avivagen Inc (CVE:VIV) shares were down 7.4% during mid-day trading on Thursday . The company traded as low as C$0.49 and last traded at C$0.50, approximately 161,500 shares were traded during trading. An increase of 286% from the average daily volume of 41,888 shares. The stock had previously closed at C$0.54.

The stock has a market capitalization of $17.45 million and a PE ratio of -3.12. The company has a quick ratio of 1.67, a current ratio of 2.07 and a debt-to-equity ratio of 2,402.32. The stock’s 50 day moving average price is C$0.58 and its 200-day moving average price is C$0.68.

Avivagen (CVE:VIV) last issued its earnings results on Friday, September 6th. The company reported C($0.04) earnings per share (EPS) for the quarter. The firm had revenue of C$0.01 million for the quarter. As a group, sell-side analysts predict that Avivagen Inc will post 1.0499999 earnings per share for the current fiscal year.

About Avivagen (CVE:VIV)

Avivagen Inc develops and commercializes various products to replace antibiotics in livestock feeds to optimize the health and growth of the animals by supporting the animal's own health defenses. The company offers products based on its OxC-Beta technology, such as OxC-beta Livestock, a premix for livestock feeds; and Vivamune Health Chews supplements for companion animals.

Further Reading: Technical Indicators – What is a Golden Cross?

Receive News & Ratings for Avivagen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avivagen and related companies with MarketBeat.com's FREE daily email newsletter.